OBJECTIVE: However experimental studies show that blood cardioplegia has a superiority than crystalloid cardioplegia in myocardial protection, clinical data is undetermined yet. There is no consensus on the selection of the cardioplegia type in open heart surgery nowadays.
METHODS: 107 patients which operated by on pump in 17 monthly period assessed retrospectively. Patients were divided in two group that using blood cardioplegia (Group1, n=72) and crystalloid cardioplegia (Group2, n=35). At preoperative demographic distribution at operated patients; patients number, mean of age, EF (Ejection Fraction), male sex in group 1, Diabetes Mellitus (DM) and female sex group 2 found more expressive. Because of risk equilibrium is not maintained this situation can be seen the weak pointof retrospective study.
RESULTS: In the end of the study postoperative bleeding volume (1077 ml), the revision rate due to bleeding (9 patients) and extubation time (345 min) in intensive care unit were significantly higher in Group I (p<0.05), while the urine volume in postoperative day 1 (1831 ml) and the inotrop use (%20) were significantly higher in Group II (p<0.05).
CONCLUSION: In open heart surgery, the crystalloid use cardioplegia were better than blood cardioplegia.

In noncardiac surgery of cardiac patients, all efforts during the preoperative assessment are to predict, and prevent potential complications An urgent operation was decided to be performed on a 80-year-old female patient with the diagnosis of depression fracture of L1. During assessment of the patient before anesthesia, we learned that patient had coronary artery disease. During the physical examination, pulmonary edema was detected secondary to the congestive heart failure. The patient was sent to coronary intensive care unit after talking with patient’s relatives and the attending surgeon. After aggressive treatment about a week, blood gas values were improved and hemodynamic values were stabilized. In this condition, we decided operation for the patient. Invasive monitorization was performed in the operation room. For induction of anesthesia, midazolam, fentanyl, rocuronium, and lidocaine were given. The maintenance of anesthesia provided with sevoflurane plus 50 % of air and 50 % of oxygen. The patient remained stable during the operation. A three-hour operation was completed without any problem, and she was remained at a steady state up to the discharge. As a conclusion, each patient should be questioned and examined carefully about cardiac manifestations during the preoperative assessment. In the presence of any sign or symptom of congestive heart failure (CHF), noncardiac surgeries should be postponed if it is not urgent. Such patients should be treated aggressively during the perioperative period according to the functional degree of CHF. In case of emergency, consultation with cardiologists should arrive at a consensus, and patients should be operated under optimal conditions.

Central venous cannulation is an invasive procedure used for total parenteral nutrition, vasoactive or venoirritating drug use, massive and rapid volume transfusion, hemodynamic monitorization, hemodialysis and percutaneous pacemaker implantations. Various complications may occur during or after this percutaneous procedure at an incidence of 5%-19%. One of the rare complications is Horner’s Syndrome. In this report, case of Horner’s Syndrome after internal jugular vein catheterization for central venous catheterization which was placed as a routine procedure in the coronary revascularization procedure was presented.

Nosocomial infections are most frequently observed in intensive care units of hospitals. Urinary tract infections appear in the first place among nosocomial infections. Several studies have demonstrated that use of urinary catheters have a direct relationship with nosocomial urinary tract infections. In recent years, UroShield™ (UroShield™ Nanovibronix Ltd. Nesher, Israel) which is a new tool developed for the prevention of urinary tract infections. UroShield™ is a device that is attached on the urinary catheter and generates continuous ultrasonic waves which are supposed to block the biofilm development by bacteria on urinary catheter In this preliminary study, we aimed to evaluate urinary tract infections whether developed or not in four patients whom we used Uroshield™.